Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013, Article ID 171437, 18 pages
http://dx.doi.org/10.1155/2013/171437
Research Article

TNF-α and IFN-s-Dependent Muscle Decay Is Linked to NF- B- and STAT-1α-Stimulated Atrogin1 and MuRF1 Genes in C2C12 Myotubes

1Department of Physiological Sciences, Faculty of Veterinary Medicine, Warsaw University of Life Sciences—SGGW, Nowoursynowska 159, 02-776 Warsaw, Poland
2Electron Microscopy Platform, Mossakowski Medical Research Centre, Polish Academy of Sciences, Pawińskiego 5, 02-106 Warsaw, Poland

Received 4 July 2013; Revised 9 September 2013; Accepted 4 October 2013

Academic Editor: Elaine Hatanaka

Copyright © 2013 Barbara Pijet et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. J. Evans, J. E. Morley, J. Argilés et al., “Cachexia: a new definition,” Clinical Nutrition, vol. 27, no. 6, pp. 793–799, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. J. Tisdale, “Mechanisms of cancer cachexia,” Physiological Reviews, vol. 89, no. 2, pp. 381–410, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Hasselgren and J. E. Fischer, “Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation,” Annals of Surgery, vol. 233, no. 1, pp. 9–17, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. J. L. Cheshire and A. S. Baldwin Jr., “Synergistic activation of NF-κB by tumor necrosis factor alpha and gamma interferon via enhanced IκBα degradation and de novo IκBβ degradation,” Molecular and Cellular Biology, vol. 17, no. 11, pp. 6746–6754, 1997. View at Google Scholar · View at Scopus
  5. D. C. Guttridge, M. W. Mayo, L. V. Madrid, C.-Y. Wang, and J. Baldwin A.S. Jr., “NF-κB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia,” Science, vol. 289, no. 5488, pp. 2363–2366, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Acharyya, K. J. Ladner, L. L. Nelsen et al., “Cancer cachexia is regulated by selective targeting of skeletal muscle gene products,” The Journal of Clinical Investigation, vol. 114, no. 3, pp. 370–378, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. M. T. Wheeler, E. C. Snyder, M. N. Patterson, and S. J. Swoap, “An E-box within the MHC IIB gene is bound by MyoD and is required for gene expression in fast muscle,” American Journal of Physiology—Cell Physiology, vol. 276, no. 5, pp. C1069–C1078, 1999. View at Google Scholar · View at Scopus
  8. M. Dehoux, C. Gobier, P. Lause, L. Bertrand, J. Ketelslegers, and J. Thissen, “IGF-I does not prevent myotube atrophy caused by proinflammatory cytokines despite activation of Akt/Foxo and GSK-3β pathways and inhibition of atrogin-1 mRNA,” American Journal of Physiology—Endocrinology and Metabolism, vol. 292, no. 1, pp. E145–E150, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Cong, L. Sun, C. Liu, and P. Tien, “Inhibition of atrogin-1/MAFbx expression by adenovirus-delivered small hairpin RNAs attenuates muscle atrophy in fasting mice,” Human Gene Therapy, vol. 22, no. 3, pp. 313–324, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. S. M. Ebert, M. C. Dyle, S. D. Kunkel et al., “Stress-induced skeletal muscle Gadd45a expression reprograms myonuclei and causes muscle atrophy,” The Journal of Biological Chemistry, vol. 287, pp. 27290–27301, 2012. View at Google Scholar
  11. A. Fanzani, V. M. Conraads, F. Penna, and W. Martinet, “Molecular and cellular mechanisms of skeletal muscle atrophy: an update,” Journal of Cachexia, Sarcopenia and Muscle, vol. 3, pp. 163–179, 2012. View at Google Scholar
  12. K. Sakuma and A. Yamaguchi, “Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass,” Journal of Cachexia, Sarcopenia and Muscle, vol. 3, pp. 77–94, 2012. View at Google Scholar
  13. A. Bonetto, T. Aydogdu, X. Jin et al., “JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia,” American Journal of Physiology—Endocrinology and Metabolism, vol. 303, pp. E410–E421, 2011. View at Google Scholar
  14. A. Bonetto, T. Aydogdu, N. Kunzevitzky et al., “STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia,” PLoS ONE, vol. 6, no. 7, Article ID e22538, 17 pages, 2012. View at Google Scholar · View at Scopus
  15. J. De Larichaudy, A. Zufferli, F. Serra et al., “TNF-α- and tumor-induced skeletal muscle atrophy involves sphingolipid metabolism,” Skeletal Muscle, vol. 2, pp. 2–19, 2012. View at Google Scholar
  16. L. G. Melstrom, K. A. Melstrom Jr., X.-Z. Ding, and T. E. Adrian, “Mechanisms of skeletal muscle degradation and its therapy in cancer cachexia,” Histology and Histopathology, vol. 22, no. 7–9, pp. 805–814, 2007. View at Google Scholar · View at Scopus
  17. X. Zhou, J. L. Wang, J. Lu et al., “Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival,” Cell, vol. 142, no. 4, pp. 531–543, 2011. View at Google Scholar · View at Scopus
  18. M. Karin and A. Lin, “NF-κB at the crossroads of life and death,” Nature Immunology, vol. 3, no. 3, pp. 221–227, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Cai, J. D. Frantz, N. E. Tawa Jr. et al., “IKKβ/NF-κB activation causes severe muscle wasting in mice,” Cell, vol. 119, no. 2, pp. 285–298, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Mourkioti and N. Rosenthal, “NF-κB signaling in skeletal muscle: prospects for intervention in muscle diseases,” Journal of Molecular Medicine, vol. 86, no. 7, pp. 747–759, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. S. A. Reed, S. M. Senf, E. W. Cornwell, S. C. Kandarian, and A. R. Judge, “Inhibition of IkappaB kinase alpha (IKKα) or IKKbeta (IKKβ) plus forkhead box O (Foxo) abolishes skeletal muscle atrophy,” Biochemical and Biophysical Research Communications, vol. 405, no. 3, pp. 491–496, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Yaffe and O. Saxel, “Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle,” Nature, vol. 270, no. 5639, pp. 725–727, 1977. View at Google Scholar · View at Scopus
  23. M. D. Jacobson, J. F. Burne, and M. C. Raff, “Programmed cell death and Bcl-2 protection in the absence of a nucleus,” The EMBO Journal, vol. 13, no. 8, pp. 1899–1910, 1994. View at Google Scholar · View at Scopus
  24. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Google Scholar · View at Scopus
  25. J. M. Argilés, S. Busquets, M. Toledo, and F. J. López-Soriano, “The role of cytokines in cancer cachexia,” Current Opinion in Supportive and Palliative Care, vol. 3, no. 4, pp. 263–268, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. J. E. Morley, D. R. Thomas, and M. G. Wilson, “Cachexia: pathophysiology and clinical relevance,” American Journal of Clinical Nutrition, vol. 83, no. 4, pp. 735–743, 2006. View at Google Scholar · View at Scopus
  27. T. A. Zimmers, M. V. Davies, L. G. Koniaris et al., “Induction of cachexia in mice by systemically administered myostatin,” Science, vol. 296, no. 5572, pp. 1486–1488, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Busquets, M. Toledo, M. Orpí et al., “Myostatin blockage using actRIIB antagonism in mice bearing the Lewis lung carcinoma results in the improvement of muscle wasting and physical performance,” Journal of Cachexia, Sarcopenia and Muscle, vol. 3, pp. 37–43, 2012. View at Google Scholar
  29. M. Pijet, B. Pijet, A. Litwiniuk, B. Pająk, B. Gajkowska, and A. Orzechowski, “Leptin impairs myogenesis in C2C12 cells through JAK/STAT and MEK signaling pathways,” Cytokine, vol. 61, pp. 445–454, 2013. View at Google Scholar
  30. E. E. Spangenburg and F. W. Booth, “Multiple signaling pathways mediate LIF-induced skeletal muscle satellite cell proliferation,” American Journal of Physiology—Cell Physiology, vol. 283, no. 1, pp. C204–C211, 2002. View at Google Scholar · View at Scopus
  31. J. M. Argiles, S. Bosquets, and F. J. Lopez-Soriano, “Cytokines in the pathogenesis of cancer cachexia,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 6, pp. 401–406, 2003. View at Google Scholar
  32. M. Buck and M. Chojkier, “Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants,” The EMBO Journal, vol. 20, pp. 6712–6723, 1996. View at Google Scholar
  33. S. Di Marco, R. Mazroui, P. Dallaire et al., “NF-κB-mediated MyoD decay during muscle wasting requires nitric oxide synthase mRNA stabilization, HuR protein, and nitric oxide release,” Molecular and Cellular Biology, vol. 25, no. 15, pp. 6533–6545, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. D. C. Guttridge, C. Albanese, J. Y. Reuther, R. G. Pestell, and A. S. Baldwin Jr., “NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1,” Molecular and Cellular Biology, vol. 19, no. 8, pp. 5785–5799, 1999. View at Google Scholar · View at Scopus
  35. S. Bhatnagar, S. K. Panguluri, S. K. Gupta, S. Dahiya, R. F. Lundy, and A. Kumar, “Tumor necrosis factor-α regulates distinct molecular pathways and gene networks in cultured skeletal muscle cells,” PLoS ONE, vol. 5, no. 10, Article ID e13262, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Lu, J. D. Proto, L. Guo et al., “NF-κB negatively impacts the myogenic potential of muscle-derived stem cells,” Molecular Therapy, vol. 20, no. 3, pp. 661–668, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Giampietri, S. Petrungaro, P. Coluccia et al., “c-flip overexpression affects satellite cell proliferation and promotes skeletal muscle aging,” Cell Death and Disease, vol. 1, no. 4, article e38, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Kataoka, R. C. Budd, N. Holler et al., “The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways,” Current Biology, vol. 10, no. 11, pp. 640–648, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. R. J. Dunlop and C. W. Campbell, “Cytokines and advanced cancer,” Journal of Pain and Symptom Management, vol. 20, no. 3, pp. 214–232, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. R. W. Jackman and S. C. Kandarian, “The molecular basis of skeletal muscle atrophy,” American Journal of Physiology—Cell Physiology, vol. 287, no. 4, pp. C834–C843, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Wang, T. R. Wu, S. Cai, T. Welte, and Y. E. Chin, “Stat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-κB activation,” Molecular and Cellular Biology, vol. 20, no. 13, pp. 4505–4512, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. D. R. Wesemann and E. N. Benveniste, “STAT-1α and IFN-γ as modulators of TNF-α signaling in macrophages: regulation and functional implications of the TNF receptor 1:STAT-1α complex,” Journal of Immunology, vol. 171, no. 10, pp. 5313–5319, 2003. View at Google Scholar · View at Scopus
  43. D. R. Wesemann, H. Qin, N. Kokorina, and E. N. Benveniste, “TRADD interacts with STAT1-α and influences interferon-γ signaling,” Nature Immunology, vol. 5, no. 2, pp. 199–207, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. B. Pajak and A. Orzechowski, “IFN-alpha competes with TNF-alpha for STAT-1alpha; molecular basis for immune escape of human colon adenocarcinoma COLO 205 cells,” Oncology Reports, vol. 18, no. 4, pp. 1039–1045, 2007. View at Google Scholar · View at Scopus
  45. C. S. Mitsiades, N. Mitsiades, V. Poulaki et al., “Activation of NF-ΚB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications,” Oncogene, vol. 21, no. 37, pp. 5673–5683, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Jobin, C. A. Bradham, M. P. Russo et al., “Curcumin blocks cytokine-mediated NF-κB activation and proinflammatory gene expression by inhibiting inhibitory factor I-κB kinase activity,” Journal of Immunology, vol. 163, no. 6, pp. 3474–3483, 1999. View at Google Scholar · View at Scopus
  47. N. B. Kumar, A. Kazi, T. Smith et al., “Cancer cachexia: traditional therapies and novel molecular mechanism-based approaches to treatment,” Current Treatment Options in Oncology, vol. 11, no. 3-4, pp. 107–117, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. S. C. Bodine, E. Latres, S. Baumhueter et al., “Identification of ubiquitin ligases required for skeletal Muscle Atrophy,” Science, vol. 294, no. 5547, pp. 1704–1708, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. M. D. Gomes, S. H. Lecker, R. T. Jagoe, A. Navon, and A. L. Goldberg, “Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 25, pp. 14440–14445, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Acharyya and D. C. Guttridge, “Cancer cachexia signaling pathways continue to emerge yet much still points to the proteasome,” Clinical Cancer Research, vol. 13, no. 5, pp. 1356–1361, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. Y. Tan, X. Peng, F. Wang, Z. You, Y. Dong, and S. Wang, “Effects of tumor necrosis factor-alpha on the 26S proteasome and 19S regulator in skeletal muscle of severely scalded mice,” Journal of Burn Care and Research, vol. 27, no. 2, pp. 226–233, 2006. View at Google Scholar · View at Scopus
  52. B. Pajak, S. Orzechowska, B. Pijet et al., “Crossroads of cytokine signaling: the chase to stop muscle cachexia,” Journal of Physiology and Pharmacology, vol. 59, supplement 9, pp. 251–264, 2008. View at Google Scholar · View at Scopus